Table I.
Association between KIN17 expression and the clinicopathological characteristics of patients with non-small cell lung cancer.
| KIN17 expression, no. of patients (%) | ||||
|---|---|---|---|---|
| Clinicopathological characteristics | Low | High | No. of patients (%) | P-value |
| Age (years) | 50.3±7.9 | 52.2±8.7 | 0.381a | |
| Tumor size (mm) | 0.2122 | |||
| ≤29.4 | 15 (65.2) | 17 (48.6) | 32 (55.2) | |
| >29.4 | 8 (34.8) | 18 (51.4) | 26 (44.8) | |
| Lymph node metastasis | 0.0362 | |||
| No | 15 (65.2) | 13 (37.1) | 28 (48.3) | |
| Yes | 8 (34.8) | 22 (62.9) | 30 (51.7) | |
| Tumor grade | 0.0202 | |||
| 1 | 9 (39.1) | 4 (11.4) | 13 (22.4) | |
| 2 | 11 (47.8) | 18 (51.4) | 29 (50.0) | |
| 3 | 3 (13.1) | 13 (37.1) | 16 (27.6) | |
| NSE expression status | 0.9012 | |||
| Negative | 13 (68.4) | 18 (66.7) | 31 (67.4) | |
| Positive | 6 (31.6) | 9 (33.3) | 15 (32.6) | |
| TTF-1 expression status | 0.3802 | |||
| Negative | 17 (73.9) | 22 (62.9) | 39 (67.2) | |
| Positive | 6 (26.1) | 13 (37.1) | 19 (32.8) | |
| CEA expression status | 0.6342 | |||
| Negative | 13 (68.4) | 16 (61.5) | 29 (64.4) | |
| Positive | 6 (31.6) | 10 (38.5) | 16 (35.6) | |
a
Student's t-test
b
χ2 test. KIN17, KIN17 DNA and RNA binding protein. NSE, neuron-specific enolase; TTF-1, thyroid transcription factor 1; CEA, carcinoembryonic antigen.